What does CUSIP Y95308105 represent in this 13F holders report?

CUSIP Y95308105 is the security identifier for WVE - Wave Life Sciences, Inc. - Ordinary Shares, no par value used to aggregate holder disclosures.

How many institutions held WVE - Wave Life Sciences, Inc. - Ordinary Shares, no par value in Q1 2023?

72 institutional investors reported WVE - Wave Life Sciences, Inc. - Ordinary Shares, no par value for Q1 2023. Use the holders table for investor-level position and value details.

Wave Life Sciences, Inc. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Ordinary Shares, no par value
Total 13F shares: 70,086,593
Total 13F value: $303,466,627
Share change: +1,950,561
Put/Call ratio: 23%
SEC-reported price per share: $4.33
Number of holders: 72
Value change: +$3,780,454
Number of buys: 41
Number of sells: 33
Shares outstanding: 188,679,245

Security key

Y95308105

Report period

Q1 2023

Institutions

Top holders

WVE full security history Ownership snapshot Full 13F holder table Wave Life Sciences Ltd. SEC filings Wave Life Sciences Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of WVE - Wave Life Sciences, Inc. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 9.1% Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 9.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 9.1%

MAVERICK CAPITAL LTD 3.8%

683 Capital Management, LLC 3.2%

M28 Capital Management LP 3.1%

ADAGE CAPITAL PARTNERS GP, L.L.C. 2.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	9.1%	$120,414,063 17,202,009 shares	—	31 Dec 2022
MAVERICK CAPITAL LTD	13F Company 13F	3.8%	$49,683,648 7,097,664 shares	—	31 Dec 2022
683 Capital Management, LLC	13F Company 13F	3.2%	$42,000,000 6,000,000 shares	—	31 Dec 2022
M28 Capital Management LP	13F Company 13F	3.1%	$41,323,835 5,903,405 shares	—	31 Dec 2022
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	2.9%	$38,688,188 5,526,884 shares	—	31 Dec 2022
Bellevue Group AG	13F Company 13F	2.4%	$31,461,206 4,494,458 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

70,086,593

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %